ResearcherImmodulon Therapeutics (United Kingdom)No recent work listed

Hilary Bilyard

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5013664399. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2014: 1 paper

Papers 1

IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer Co-author DOI 10.1186/2051-1426-2-s3-p83 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Laura Rosa Brunet · 1 shared paper, 2014 · strength 0.06
- Paper IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer DOI 10.1186/2051-1426-2-s3-p83 ↗
Frances Macintosh · 1 shared paper, 2014 · strength 0.06
- Paper IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer DOI 10.1186/2051-1426-2-s3-p83 ↗
Angus George Dalgleish · 1 shared paper, 2014 · strength 0.06
- Paper IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer DOI 10.1186/2051-1426-2-s3-p83 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.